Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: Contribution of stromal cells to their production and correlation with metastasis

Cancer Research

Volumn 58, Issue 10, 1998, Pages 2209-2216

  Sugiura, Yasuo ^a   Shimada, Hiroyuki ^b   Seeger, Robert C ^a   Laug, Walter E ^a   DeClerck, Yves A ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHENYLMERCURIC ACETATE; CONCANAVALIN A; GELATINASE A; GELATINASE B; MERCURY DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; METASTASIS; NEUROBLASTOMA; NEUROBLASTOMA CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL;

COLLAGENASES; ENZYME ACTIVATION; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; NEOPLASM PROTEINS; NEUROBLASTOMA; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR CELLS, CULTURED;

EID: 0032523792     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Brodeur, G. M., Seeger, R. C., Barrett, A., Berthold, F., Castleberry, R. P., D' Angio, G., De Bernardi, B., Evans, A. E., Favrot, M., and Freeman, A. I. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol., 6: 1874-1881, 1988.
2. Reynolds, C. P., and Seeger, R. C. Neuroblastoma. In: C. M. Haskell (ed.), Cancer Treatment, pp. 860-871. Philadelphia: W. B. Saunders, 1994.
3. Shimada, H., Chatten, J., Newton, W., Jr., Sachs, N., Hamoudi, A. B., Chiba, T., Marsden, H. B., and Misugi, K. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastoma. J. Natl. Cancer Inst., 73: 405-416, 1984.
4. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
5. Matrisian, L. M. The matrix degrading metalloproteinases. Bioessays, 14: 455-463, 1992.
6. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond.), 370: 61-65, 1994.
7. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg, G. I. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem., 270: 5331-5338, 1995.
8. Pei, D., and Weiss, S. J. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem., 271: 9135-9140, 1996.
9. Nagase, H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. Hoppe Seyler, 378: 151-160, 1997.
10. Ginestra, A., Monea, S., Seghezzi, G., Dolo, V., Nagase, H., Mignatti, P., and Vittorelli, M. L. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J. Biol. Chem., 272: 17216-17222, 1997.
11. Devy, L., Noel, A., Baramova, E., Bajou, K., Trentesaux, C., Jardillier, J. C., Foidart, J. M., and Jeannesson, P. Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells. Biochem. Biophys. Res. Commun., 238: 842-846, 1997.
12. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P. Control of type IV collagenase activity by components of the urokinaseplasmin system: a regulatory mechanism with cell-bound reactants. EMBO J., 16: 2319-2332, 1997.
13. Denhardt, D. T., Feng, B., Edwards, D. R., Cocuzzi, E. T., and Malyankar, U. M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther., 59: 329-341, 1993.
14. DeClerck, Y. A., Yean, T. D., Lu, H. S., Ting, J., and Langley, K. E. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem., 266: 3893-3899, 1991.
15. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., and Marmer, B. L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem., 267: 4583-4591, 1992.
16. Ray, J. M., and Stetler-Stevenson, W. G. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J., 7: 2062-2072, 1994.
17. Chambers, A. F., and Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst., 89: 1260-1270, 1997.
18. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 4: 541-573, 1993.
19. Kossakowska, A. E., Huchcroft, S. A., Urbanski, S. J., and Edwards, D. R. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br. J. Cancer, 73: 1401-1408, 1996.
20. Himelstein, B. P., Canete Soler, R., Bernhard, E. J., Dilks, D. W., and Muschel, R. J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis, 14: 246-258, 1994.
21. Kawano, N., Osawa, H., Ito, T., Nagashima, Y., Hirahara, F., Inayama, Y., Nakatani, Y., Kimura, S., Kitajima, H., Koshikawa, N., Miyazaki, K., and Kitamura, H. Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study. Hum. Pathol., 28: 613-622, 1997.
22. Tokuraku, M., Sato, H., Murakami, S., Okada, Y., Watanabe, Y., and Seiki, M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int. J. Cancer, 64: 355-359, 1995.
23. Wood, M., Fudge, K., Mohler, J. L., Frost, A. R., Garcia, F., Wang, M., and Stearns, M. E. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin. Exp. Metastasis, 15: 246-258, 1997.
24. Rha, S. Y., Kim, J. H., Roh, J. K., Lee, K. S., Min, J. S., Kim, B. S., and Chung, H. C. Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression. Breast Cancer Res. Treat., 43: 175-181, 1997.
25. Newell, K. J., Witty, J. P., Rodgers, W. H., and Matrisian, L. M. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol. Carcinog., 10: 199-206, 1994.
26. Heppner, K. J., Matrisian, L. M., Jensen, R. A., and Rodgers, W. H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumorinduced host response. Am. J. Pathol., 149: 273-282, 1996.
27. Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., and Chambon, P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.), 348: 699-704, 1990.
28. Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P., and Basset, P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA, 92: 2730-2744, 1995.
29. Nielsen, B. S., Timshel, S., Kjeldsen, L., Sehested, M., Pyke, C., Borregaard, N., and Dano, K. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer, 65: 57-62, 1996.
30. Lim, Y. T., Sugiura, Y., Laug, W. E., Sun, B., Garcia, A., and DeClerck, Y. A. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. J. Cell Physiol., 167: 333-340, 1996.
31. Chirgwin, J. M., Przybyla, A. E., McDonald, R. J., and Rotter, W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18: 5294-5299, 1979.
32. Strongin, A. Y., Marmer, B. L., Grant, G. A., and Goldberg, G. I. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem., 268: 14033-14039, 1993.
33. Ramamurthy, N. S., Vernillo, A. T., Lee, H. M., Golub, L. M., and Rifkin, B. R. The effect of tetracyclines on collagenase activity in UMR 106-01 rat osteoblastic osteosarcoma cells. Res. Commun. Chem. Pathol. Pharmacol., 70: 323-335, 1990.
34. Ueno, H., Nakamura, H., Inoue, M., Imai, K., Noguchi, M., Sato, H., Seiki, M., and Okada, Y. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res., 57: 2055-2060, 1997.
35. Burnette, W. N. Western blotting: electrophoretic transfer of proteins from sodium dodecylsulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Ann. Biochem., 112: 195-203, 1981.
36. Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P., and Edwards, D. R. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J. Biol. Chem., 269: 9352-9360, 1994.
37. Yu, M., Bowden, E. T., Sitlani, J., Sato, H., Seiki, M., Mueller, S. C., and Thompson, E. W. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metallo-proteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells. Cancer Res., 57: 5028-5032, 1997.
38. de Veas, R. G., Schweigerer, L., and Medina, M. A. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in paediatric tumour cells. Effects of tumour cell proliferation modulators on gelatinolytic activity. J. Cancer Res. Clin. Oncol., 121: 275-278, 1995.
39. Fowler, C., Zimmer, C., Boghaert, E., Thomas, M., and Zimmer, S. Metastasis of C1300 and TBJ murine neuroblastomas correlates with expression of matrix metalloproteinases. Cancer Lett., 93: 171-177, 1995.
40. Taguchi, K., Yoshida, K., Sasaki, F., and Fujinaga, K. Two transcription factors, E1AF and N-myc, correlate with the invasiveness of neuroblastoma cell lines. Jpn. J. Cancer. Res., 88: 394-400, 1997.
41. Negro, A., Onisto, M., Pellati, D., and Garbisa, S. CNTF up-regulation of TIMP-2 in neuroblastoma cells. Mol. Brain Res., 48: 30-36, 1997.
42. Rao, V. H., Singh, R. K., Bridge, J. A., Neff, J. R., Schaefer, G. B., Delimont, D. C., Dunn, C. M., Sanger, W. G., Buehler, B. A., Sawaya, R., Nicolson, G. L., and Rao, J. S. Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone. Clin. Exp. Metastasis, 15: 400-409, 1997.
43. Himelstein, B. P., Canete Soler, R., Bernhard, E. J., and Muschel, R. J. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J. Cell. Sci., 107: 477-486, 1994.
44. Miyagi, E., Yasumitsu, H., Hirahara, F., Nagashima, Y., Minaguchi, H., Miyazaki, K., and Umeda, M. Marked induction of gelatinases, especially type B, in host fibroblasts by human ovarian cancer cells in athymic mice. Clin. Exp. Metastasis, 13: 89-96, 1995.
45. Segain, J. P., Harb, J., Gregoire, M., Meflah, K., and Menanteau, J. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. Cancer Res., 56: 5506-5512, 1996.
46. Shapiro, S. D., Fliszar, C. J., Broekelmann, T. J., Mecham, R. P., Senior, R. M., and Welgus, H. G. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J. Biol. Chem., 270: 6351-6356, 1995.
47. Fridman, R., Toth, M., Pena, D., and Mobashery, S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res., 55: 2548-2555, 1995.
48. Morodomi, T., Ogata, Y., Sasaguri, Y., Morimatsu, M., and Nagase, H. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem. J., 285: 603-611, 1992.
49. Bernhard, E. J., Gruber, S. B., and Muschel, R. J. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA, 91: 4293-4297, 1994.
50. Ueda, Y., Imai, K., Tsuchiya, H., Fujimoto, N., Nakanishi, I., Katsuda, S., Seiki, M., and Okada, Y. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am. J. Pathol., 148: 611-622, 1996.
51. Zeng, Z. S., Huang, Y., Cohen, A. M., and Guillem, J. G. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J. Clin. Oncol., 14: 3133-3140, 1996.
52. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res., 53: 140-146, 1993.
53. Reynolds, C. P., Tomayko, M. M., Donner, L., Helson, L., Seeger, R. C., Triche, T. J., and Brodeur, G. M. Biological classification of cell lines derived from human extra-cranial neural tumors. Prog. Clin. Biol. Res., 271: 291-306, 1988.